학술논문

Yttrium-90 Ibritumomab Tiuxetan as a Single Agent in Patients With Pretreated B-Cell Lymphoma: Evaluation of the Long-Term Outcome
Document Type
Article
Source
In Clinical Lymphoma Myeloma and Leukemia August 2010 10(4):258-261
Subject
Original Studies
Language
ISSN
2152-2650